Comparative study between myeloablative conditioning and reduced intensity conditioning regimens for allogenic stem cell transplantation in myelodysplastic syndromes /
Azza Shehata Ragab Sarhan
Comparative study between myeloablative conditioning and reduced intensity conditioning regimens for allogenic stem cell transplantation in myelodysplastic syndromes / زرع النخاع باستخدام العلاج الكيميائي المدمر لخلايا النخاع العظمي مقارنة باستخدام العلاج الكيميائي مخفف الشدة في علاج متلازمة خلل نمو النخاع العظمي Azza Shehata Ragab Sarhan ; Supervised Omar Abdelrahman Fahmy , Mohamed Abdelmooti Samra , Raafat Mohamed Abdelfattah - Cairo : Azza Shehata Ragab Sarhan , 2011 - 192 P. : charts ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Medicine. - Department of Internal Medicine
Stem cell transplantation offers potentially curative therapy for patients with myelodysplastic syndrome. A broad scale regimens, ranging from "modified" conventional to reduced intensity to non-myeloablative regimens, has been developed and used successfully; one size does not appear to fit all. Rather, patient age, co-morbid conditions, disease stage, ferretin level, presence and severity of myelofibrosis, non-transplant chemotherapy, type of donor, source of stem cell, and other factors, all affect the decision regarding transplantation and impact on outcome
Conditioning regimen Myelodysplastic syndromes Nonmyeloablative
Comparative study between myeloablative conditioning and reduced intensity conditioning regimens for allogenic stem cell transplantation in myelodysplastic syndromes / زرع النخاع باستخدام العلاج الكيميائي المدمر لخلايا النخاع العظمي مقارنة باستخدام العلاج الكيميائي مخفف الشدة في علاج متلازمة خلل نمو النخاع العظمي Azza Shehata Ragab Sarhan ; Supervised Omar Abdelrahman Fahmy , Mohamed Abdelmooti Samra , Raafat Mohamed Abdelfattah - Cairo : Azza Shehata Ragab Sarhan , 2011 - 192 P. : charts ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Medicine. - Department of Internal Medicine
Stem cell transplantation offers potentially curative therapy for patients with myelodysplastic syndrome. A broad scale regimens, ranging from "modified" conventional to reduced intensity to non-myeloablative regimens, has been developed and used successfully; one size does not appear to fit all. Rather, patient age, co-morbid conditions, disease stage, ferretin level, presence and severity of myelofibrosis, non-transplant chemotherapy, type of donor, source of stem cell, and other factors, all affect the decision regarding transplantation and impact on outcome
Conditioning regimen Myelodysplastic syndromes Nonmyeloablative